These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 30064892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis.
    Pavlov-Dolijanovic SR, Vujasinovic Stupar NZ, Gavrilov N, Seric S.
    Rheumatol Int; 2014 Nov; 34(11):1615-8. PubMed ID: 24789670
    [Abstract] [Full Text] [Related]

  • 3. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
    Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM, Sebring N, O'Hanlon TP, Ruiz-Hidalgo M, Turner M, Gordon LB, Laborda J, Bauer SR, Blackshear PJ, Imundo L, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study Group.
    Medicine (Baltimore); 2008 Mar; 87(2):70-86. PubMed ID: 18344805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical outcomes in juvenile dermatomyositis.
    Ramanan AV, Feldman BM.
    Curr Opin Rheumatol; 2002 Nov; 14(6):658-62. PubMed ID: 12410087
    [Abstract] [Full Text] [Related]

  • 9. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis.
    Orandi AB, Dharnidharka VR, Al-Hammadi N, Baszis KW, CARRA Legacy Registry Investigators.
    Pediatr Rheumatol Online J; 2018 Dec 29; 16(1):84. PubMed ID: 30594206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Using imaging methods to assess severe calcinosis in juvenile dermatomyositis: A case report.
    Xu H, Wang L, Wei S, Li C, Yuan K.
    Int J Rheum Dis; 2023 Mar 29; 26(3):554-558. PubMed ID: 36539990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Juvenile amyopathic dermatomyositis and calcinosis].
    Escorial Briso-Montiano M, Solís Sánchez P, Baeza Velasco M, Alonso Rubio A, de Gregorio Alvarez Z.
    An Pediatr (Barc); 2005 Mar 29; 62(3):286-8. PubMed ID: 15737292
    [Abstract] [Full Text] [Related]

  • 15. [Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes].
    Vatier C, Jéru I, Fellahi S, Capeau J, Bastard JP, Vigouroux C, groupe de travail RIHN Adipokines.
    Ann Biol Clin (Paris); 2020 Jun 01; 78(3):261-264. PubMed ID: 32420889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
    Sharma A, Gupta A, Rawat A, Suri D, Singh S.
    Int J Rheum Dis; 2020 Mar 01; 23(3):392-396. PubMed ID: 31793219
    [Abstract] [Full Text] [Related]

  • 19. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.
    Saini I, Kalaivani M, Kabra SK.
    Rheumatol Int; 2016 Jul 01; 36(7):961-5. PubMed ID: 27007612
    [Abstract] [Full Text] [Related]

  • 20. Tumoral calcinosis and atypical juvenile dermatomyositis: case report.
    Liniger P, Slongo T, Eckhardt O.
    Eur J Pediatr Surg; 1998 Dec 01; 8(6):382-4. PubMed ID: 9926314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.